Skip to Main Content

Author Details

Sahussapont J Sirintrapun
Memorial Sloan Kettering Cancer Center
1996
100
27
PMIDPaper TitleJournal TitlePublished Year
37793038Examining the role of diversity, equity, and inclusion in mitigating workforce burnout in laboratory medicine.Am J Clin Pathol2024
36535703Paging the Clinical Informatics Community: Respond STAT to Dobbs v. Jackson's Women's Health Organization.Appl Clin Inform2023
37811334Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational cost.J Pathol Inform2023
37243318Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.Pediatr Blood Cancer2023
36696602Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML.Clin Chem Lab Med2023
34161656Clinical utility of subclassifying positive surgical margins at radical prostatectomy.BJU Int2022
35676169Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.Clin Genitourin Cancer2022
35731998Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.JCO Precis Oncol2022
35758203Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.Histopathology2022
35486887Using Technology to Enhance Cancer Clinical Trial Participation.Am Soc Clin Oncol Educ Book2022
37145713Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort.Urol Pract2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
34549366TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas.Endocr Pathol2022
34754075Correction: Integrating digital pathology into clinical practice.Mod Pathol2022
34599281Integrating digital pathology into clinical practice.Mod Pathol2022
32879414Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma.Mod Pathol2021
33795868Do not sell regulatory science short.Nat Med2021
33625877OncoTree: A Cancer Classification System for Precision Oncology.JCO Clin Cancer Inform2021
35155745Digital Pathology Operations at an NYC Tertiary Cancer Center During the First 4 Months of COVID-19 Pandemic Response.Acad Pathol2021
35071713<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) &amp; Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract.Bladder Cancer2021
34075769Pathology Informatics Education during the COVID-19 Pandemic at Memorial Sloan Kettering Cancer Center (MSKCC).Acta Med Acad2021
34260720Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.J Am Med Inform Assoc2021
34165509Strategic Thinking in Test Selection for Mass SARS-CoV-2 Testing.J Appl Lab Med2021
33238006Exploring the College of American Pathologists Electronic Cancer Checklists: What They Are and What They Can Do for You.Arch Pathol Lab Med2021
33439728College of American Pathologists Cancer Protocols: From Optimizing Cancer Patient Care to Facilitating Interoperable Reporting and Downstream Data Use.JCO Clin Cancer Inform2021
31496327Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.Int J Surg Pathol2020
31876541Morphologic and Immunohistochemical Assessment of CDH1 Loss of Function Alterations in Prostatic Adenocarcinoma.Am J Surg Pathol2020
32094488Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer.Prostate Cancer Prostatic Dis2020
33042604A Synoptic Electronic Order Set for Placental Pathology: A Framework Extensible to Nonneoplastic Pathology.J Pathol Inform2020
32685256The Future of Pathology: What can we Learn from the COVID-19 Pandemic?J Pathol Inform2020
32572154Validation of a digital pathology system including remote review during the COVID-19 pandemic.Mod Pathol2020
32755461Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling.JCO Clin Cancer Inform2020
32389816Upper Tract Urothelial Carcinoma in a Patient With Horseshoe Kidney.Urology2020
32452840Whole Slide Imaging: Technology and Applications.Adv Anat Pathol2020
31584841Practice Patterns in Reporting Tertiary Grades at Radical Prostatectomy: Survey of a Large Group of Experienced Urologic Pathologists.Arch Pathol Lab Med2020
29575752Rapid on-site evaluation using telecytology: A major cancer center experience.Diagn Cytopathol2019
30076908Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.J Urol2019
31238983Validation of mitotic cell quantification via microscopy and multiple whole-slide scanners.Diagn Pathol2019
31600176TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.Am J Surg Pathol2019
30838648Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.J Pathol2019
30778169Whole slide imaging equivalency and efficiency study: experience at a large academic center.Mod Pathol2019
30980040Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.Mod Pathol2019
31107718In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.Am J Surg Pathol2019
30996253JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.Mod Pathol2019
31135485PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.Am J Surg Pathol2019
30622286Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.Mod Pathol2019
30303819Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.Am J Surg Pathol2019
30300632Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.J Urol2019
29538613Preparing for a Computational Pathology Future Through Informaticians and a Computational Technologist Workforce.Am J Clin Pathol2018
  • 1 - 50 of 100

Recommended Authors

Veterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2013
Number of shared co-authors 4
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 4
University of Nebraska Medical Center
Career Start Year 2012
Number of shared co-authors 0
University of Louisville
Career Start Year 2012
Number of shared co-authors 4
Henry Ford Hospital
Career Start Year 2009
Number of shared co-authors 1
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 15
Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Career Start Year 2008
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 5
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 6
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 8
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 3
University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 19
NIHR Oxford Biomedical Research Centre
Career Start Year 2002
Number of shared co-authors 4
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 1
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 6
Walter Reed National Military Medical Center
Career Start Year 1997
Number of shared co-authors 1
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 5
Baylor College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 2
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 4
University of Pittsburgh School of Medicine
Career Start Year 1982
Number of shared co-authors 6
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 4
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 11

Collaborators

Memorial Sloan Kettering Cancer Center
Co-authored papers 32
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Co-authored papers 25
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Co-authored papers 4
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 3
Present address: Dxige Research Inc.
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Michigan Center for Translational Pathology.
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Toronto
Co-authored papers 2
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 2
Emory University School of Medicine
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Cleveland Clinic.
Co-authored papers 2
Federal University of Parana
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Stony Brook University
Co-authored papers 1
Clinical Informatics Center, UT Southwestern Medical Center
Co-authored papers 1